NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
NovAccess Global to Present at World Orphan Drug Congress
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division
NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate
NovAccess Global Announces Virtual Annual Shareholders’ Meeting
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
NovAccess Global Announces Fireside Chat with Board Member Perspectives
